Market Overview

Biosurgery Market - Global Forecast to 2023

Share:

Biosurgery Market - Global Forecast to 2023

PR Newswire

DUBLIN, July 26, 2018 /PRNewswire/ --

The "Biosurgery Market by Product (Fibrin/Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global biosurgery market is projected to reach USD 15.58 billion by 2023 from USD 11.36 billion in 2018, at a CAGR of 6.5%

The growth of this market is driven by the growing geriatric population and corresponding chronic diseases, increasing volume of surgeries and prevalence of severe trauma injuries, and rising need for effective blood loss management in patients.

The market is segmented based on products, applications, and regions. Based on the product type, the bone-graft substitutes segment accounted for the largest share of the market in 2017. The large share of this segment is attributed to the increasing use of bone-graft substitutes across different types of orthopedic surgeries as they reduce surgical time. The focus on new orthobiologic materials like stem cell bone grafts and bone-graft substitutes is also increasing as they have fewer limitations compared to autografts (such as the potential risk of infections and donor site morbidity).

By application, the biosurgery market is segmented into gynecological surgery, general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, reconstructive surgery, urological surgery, and thoracic surgery. The orthopedic surgery segment accounted for the largest share of the market in 2017. The large share of this segment is primarily attributed to the large number of orthopedic bone and soft tissue repair surgeries being performed globally, on an annual basis. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the biosurgery market for orthopedic applications.

Geographically, the global biosurgery market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of this market in 2017. This is primarily due to the increasing aging population, increasing number of trauma injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, well-established healthcare services, and advance technological adaption across North America.

On the other hand, Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The rising healthcare expenditure, growing volume of surgical procedures, and rising need for effective blood loss management in patients are driving the growth of these markets.

Key Topics Covered:

1 Biosurgery Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Biosurgery Market: Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Biosurgery Market: Executive Summary

4 Biosurgery Market: Premium Insights
4.1 Biosurgery Market: Overview
4.2 APAC: Biosurgery Market, By Type & Country (2017)
4.3 Geographic Snapshot of the Biosurgery Market (2017)
4.4 Geographic Mix: Biosurgery Market, 2016 2023 (USD Million)
4.5 Biosugery Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)

5 Biosurgery Market: Overview
5.1 Introduction
5.2 Drivers
5.2.1 Rising Geriatric Population
5.2.2 Increasing Volume of Surgeries and Prevalence of Severe Trauma Injuries
5.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products
5.2.4 Rising Need for Effective Blood Loss Management in Patients
5.3 Market Restraints
5.3.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures
5.4 Market Opportunities
5.4.1 Untapped Emerging Markets
5.5 Market Challenges
5.5.1 Stringent Regulatory Framework
5.5.2 Requirement of Skilled Personnel for the Effective Use of Biosurgery Products

6 Industry Insights
6.1 Industry Trends
6.1.1 Increasing Market Consolidation
6.1.2 Rising Focus on Product Developments & Launches
6.1.3 Growing Demand for Dental Bone-Graft Substitutes
6.1.4 Growing Preference for Gelatin-Based Adhesives & Hydrogels in Surgical Procedures
6.2 Regulatory Analysis
6.2.1 North America
6.2.1.1 US
6.2.1.2 Canada
6.2.2 Europe
6.2.3 APAC
6.2.3.1 Japan
6.2.3.2 China
6.2.3.3 India
6.3 Strategic Benchmarking
6.3.1 Biosurgery Market: Product Portfolio Analysis
6.3.2 Natural/Biological Sealants & Adhesives: Product Portfolio Analysis
6.3.3 Synthetic & Semisynthetic Sealants & Adhesives: Product Portfolio Analysis
6.3.4 Hemostatic Agents: Product Portfolio Analysis
6.3.5 Adhesion Barriers: Product Portfolio Analysis
6.3.6 Soft-Tissue Attachments: Product Portfolio Analysis
6.3.7 Bone-Graft Substitutes : Product Portfolio Analysis

7 Biosurgery Market, By Product
7.1 Introduction
7.2 Bone-Graft Substitutes
7.2.1 Demineralized Bone Matrix
7.2.2 Synthetic Bone Grafts
7.2.3 Bone Morphogenetic Proteins
7.2.4 Other Bone-Graft Substitutes
7.3 Soft-Tissue Attachments
7.3.1 Synthetic Meshes
7.3.2 Biological Meshes
7.3.2.1 Allografts
7.3.2.2 Xenografts
7.4 Hemostatic Agents
7.4.1 Thrombin-Based Hemostatic Agents
7.4.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents
7.4.3 Combination Hemostatic Agents
7.5 Surgical Sealants and Adhesives
7.5.1 Natural/Biological Sealants and Adhesives
7.5.1.1 Natural/Biological Sealants and Adhesives, By Type
7.5.1.1.1 Fibrin Sealants
7.5.1.1.2 Collagen-Based Sealants
7.5.1.1.3 Gelatin-Based Sealants
7.5.1.1.4 Albumin-Based Sealants
7.5.1.1.5 Other Natural/Biological Sealants
7.5.1.2 Natural/Biological Sealants and Adhesives, By Origin
7.5.1.2.1 Human Blood-Based Sealants and Adhesives
7.5.1.2.2 Animal-Based Sealants and Adhesives
7.5.2 Synthetic and Semi-Synthetic Sealants and Adhesives
7.5.2.1 Peg Hydrogels
7.5.2.2 Cyanoacrylate-Based Sealants and Adhesives
7.5.2.3 Urethane-Based Sealants and Adhesives
7.5.2.4 Other Synthetic and Semi-Synthetic Sealants and Adhesives
7.6 Adhesion Barriers
7.6.1 Synthetic Adhesion Barriers
7.6.1.1 Hyaluronic Acid-Based Adhesion Barriers
7.6.1.2 Regenerated Cellulose-Based Adhesion Barriers
7.6.1.3 Peg-Based Adhesion Barriers
7.6.1.4 Ther Synthetic Adhesion Barriers
7.6.2 Natural Adhesion Barriers
7.6.2.1 Collagen & Protein Adhesion Barriers
7.6.2.2 Fibrin-Based Adhesion Barriers
7.7 Staple-Line Reinforcement Agents

8 Biosurgery Market, By Application
8.1 Introduction
8.2 Orthopedic Surgery
8.3 General Surgery
8.4 Neurological Surgery
8.5 Cardiovascular Surgery
8.6 Reconstructive Surgery
8.7 Gynecological Surgery
8.8 Urological Surgery
8.9 Thoracic Surgery

9 Biosurgery Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa

10 Biosurgery Market: Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Surgical Sealants and Adhesives
10.2.2 Hemostatic Agents
10.2.3 Bone-Graft Substitutes
10.2.4 Adhesion Barriers
10.2.5 Soft-Tissue Attachments
10.3 Competitive Situations and Trends
10.3.1 Product Launches and Approvals
10.3.2 Agreements and Partnerships
10.3.3 Acquisitions
10.3.4 Expansions

11 Company Profiles
11.1 Baxter International, Inc.
11.2 B.Braun Melsungen AG
11.3 C.R. Bard
11.4 Johnson & Johnson
11.5 Medtronic, PLC.
11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
11.7 Cohera Medical Inc.
11.8 Integra Lifesciences Holdings Corporation
11.9 Commonwealth Serum Laboratories (CSL)
11.10 Hemostasis, LLC
11.11 Sanofi
11.12 Pfizer Inc.
11.13 Stryker Corporation
11.14 Cryolife, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/76xcbh/biosurgery_market?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Cision View original content:http://www.prnewswire.com/news-releases/biosurgery-market---global-forecast-to-2023-300687211.html

SOURCE Research and Markets

View Comments and Join the Discussion!